{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:01Z","timestamp":1781650681019,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hochschule Bremerhaven"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Infections associated with cardiac implantable electronic devices (CIEDs) pose significant clinical challenges due to their life-threatening nature and complex management. Recent advancements in prevention, diagnosis, and treatment have been driven by landmark trials such as PADIT and WRAP-IT, alongside evolving diagnostic tools like [18\u00a0F]FDG PET\/CT and updated diagnostic criteria (e.g., 2023 Duke-ISCVID). A combination of well-established approaches\u2014such as leadless pacemakers, subcutaneous ICDs, and an antibiotic-eluting envelope\u2014and evolving adjunctive strategies, including a taurolidine-containing antimicrobial agent, incision drapes, fascial plane blocks or double gloving, have broadened the spectrum of options to reduce and potentially mitigate the risk of CIED infection. While devices like leadless pacemakers, subcutaneous ICDs, and antibiotic envelopes are supported by randomized controlled trials, adjunctive measures such as taurolidine rely predominantly on observational data. To address this variation in the strength of available evidence, a modified Delphi consensus process was conducted, bringing together cardiologists and infectious disease experts to define experience-based best practices in areas where current guidelines offer limited or no specific recommendations. The consensus achieved strong agreement (\u2265\u200980%) on key strategies, including mandatory double-gloving to reduce contamination, the use of validated risk models (e.g., PADIT, BLISTER) for tailored infection prevention employing an antibiotic eluting envelope, multidisciplinary decision-making for non-extractable infections and the use of taurolidine solutions as adjuncts to prevent CIED infection. Moderate consensus (60\u201379%) supported non-delayed reimplantation after lead-related endocarditis and single-session reimplantation in pacing-dependent patients under specific circumstances. However, no consensus was reached on mandating a minimum annual procedural volume (\u2265\u2009500 cases) for CIED centers, reflecting concerns about access and operator expertise. The findings emphasize the importance of personalized risk stratification, procedural innovations, and multidisciplinary collaboration in optimizing CIED infection outcomes. Areas requiring further research include the efficacy of iodophor-impregnated drapes, fascial plane blocks, and taurolidine solutions. This consensus provides a pragmatic framework for clinicians, highlighting evidence-informed strategies to mitigate infection risks and improve care for patients undergoing CIED procedures.<\/jats:p>","DOI":"10.1038\/s41598-026-49515-x","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:16:01Z","timestamp":1776831361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delphi consensus recommendations for preventing and treating cardiac implantable electronic device infections beyond current guidelines"],"prefix":"10.1038","volume":"16","author":[{"given":"Benito","family":"Baldauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rapacciuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Zucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Bongiorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Casorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Mitacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hohendanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Durante","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul William Xavier","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Spencker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Steger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Zac\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojan","family":"Assadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Giaccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bonnemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"49515_CR1","doi-asserted-by":"publisher","first-page":"iv11","DOI":"10.1093\/europace\/euab071","volume":"23","author":"C Blomstrom-Lundqvist","year":"2021","unstructured":"Blomstrom-Lundqvist, C. & Ostrowska, B. Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis. Europace 23, iv11\u201319. https:\/\/doi.org\/10.1093\/europace\/euab071 (2021).","journal-title":"Europace"},{"key":"49515_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa010","author":"C Blomstrom-Lundqvist","year":"2020","unstructured":"Blomstrom-Lundqvist, C. et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa010 (2020).","journal-title":"Eur. Heart J."},{"key":"49515_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euz137","author":"V Traykov","year":"2019","unstructured":"Traykov, V. et al. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association. Europace https:\/\/doi.org\/10.1093\/europace\/euz137 (2019).","journal-title":"Europace"},{"key":"49515_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/cid\/ciad271","volume":"77","author":"VG Fowler","year":"2023","unstructured":"Fowler, V. G. et al. The 2023 Duke-international society for cardiovascular infectious diseases criteria for infective endocarditis: updating the modified duke criteria. Clin. Infect. Dis. 77, 518\u2013526. https:\/\/doi.org\/10.1093\/cid\/ciad271 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"49515_CR5","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","volume":"149","author":"LM Baddour","year":"2024","unstructured":"Baddour, L. M. et al. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation 149, e201\u2013e216. https:\/\/doi.org\/10.1161\/CIR.0000000000001187 (2024).","journal-title":"Circulation"},{"key":"49515_CR6","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/j.hrthm.2017.09.001","volume":"14","author":"FM Kusumoto","year":"2017","unstructured":"Kusumoto, F. M. et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 14, e503\u2013e551. https:\/\/doi.org\/10.1016\/j.hrthm.2017.09.001 (2017).","journal-title":"Heart Rhythm"},{"key":"49515_CR7","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","volume":"72","author":"AD Krahn","year":"2018","unstructured":"Krahn, A. D. et al. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial. J. Am. Coll. Cardiol. 72, 3098\u20133109. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.068 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"49515_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901111","author":"KG Tarakji","year":"2019","unstructured":"Tarakji, K. G. et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1901111 (2019).","journal-title":"N Engl. J. Med."},{"key":"49515_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13019-024-03059-1","volume":"19","author":"R Vonthein","year":"2024","unstructured":"Vonthein, R. et al. Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace\u2122 registry. J. Cardiothorac. Surg. 19, 592. https:\/\/doi.org\/10.1186\/s13019-024-03059-1 (2024).","journal-title":"J. Cardiothorac. Surg."},{"key":"49515_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad306","author":"S Borov","year":"2023","unstructured":"Borov, S. et al. Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection. EP Europace. https:\/\/doi.org\/10.1093\/europace\/euad306 (2023).","journal-title":"EP Europace"},{"key":"49515_CR11","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","volume":"387","author":"P Friedman","year":"2022","unstructured":"Friedman, P. et al. Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N Engl. J. Med. 387, 1292\u20131302. https:\/\/doi.org\/10.1056\/NEJMoa2206485 (2022).","journal-title":"N Engl. J. Med."},{"key":"49515_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","volume":"383","author":"RE Knops","year":"2020","unstructured":"Knops, R. E. et al. Subcutaneous or transvenous defibrillator therapy. N Engl. J. Med. 383, 526\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1915932 (2020).","journal-title":"N Engl. J. Med."},{"key":"49515_CR13","doi-asserted-by":"publisher","first-page":"e012446","DOI":"10.1161\/circep.123.012446","volume":"17","author":"E Maclean","year":"2024","unstructured":"Maclean, E. et al. The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use. Circ. Arrhythm. Electrophysiol. 17, e012446. https:\/\/doi.org\/10.1161\/circep.123.012446 (2024).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"49515_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jvir.2020.09.012","volume":"32","author":"JM Moriarty","year":"2021","unstructured":"Moriarty, J. M. et al. Endovascular Removal of Thrombus and Right Heart Masses Using the AngioVac System: Results of 234 Patients from the Prospective, Multicenter Registry of AngioVac Procedures in Detail (RAPID). J. Vasc Interv Radiol. 32, 549\u2013557e543. https:\/\/doi.org\/10.1016\/j.jvir.2020.09.012 (2021).","journal-title":"J. Vasc Interv Radiol."},{"key":"49515_CR15","doi-asserted-by":"publisher","first-page":"e20476","DOI":"10.1371\/journal.pone.0020476","volume":"6","author":"R Boulkedid","year":"2011","unstructured":"Boulkedid, R., Abdoul, H., Loustau, M., Sibony, O. & Alberti, C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One. 6, e20476. https:\/\/doi.org\/10.1371\/journal.pone.0020476 (2011).","journal-title":"PLoS One"},{"key":"49515_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.zefq.2022.04.025","volume":"172","author":"J Spranger","year":"2022","unstructured":"Spranger, J., Homberg, A., Sonnberger, M. & Niederberger, M. Reporting guidelines for Delphi techniques in health sciences: A methodological review. Z. f\u00fcr Evidenz Fortbild. und Qualit\u00e4t im Gesundheitswesen. 172, 1\u201311. https:\/\/doi.org\/10.1016\/j.zefq.2022.04.025 (2022).","journal-title":"Z. f\u00fcr Evidenz Fortbild. und Qualit\u00e4t im Gesundheitswesen"},{"key":"49515_CR17","doi-asserted-by":"publisher","first-page":"Cd003087","DOI":"10.1002\/14651858.CD003087.pub2","volume":"2006","author":"J Tanner","year":"2006","unstructured":"Tanner, J. & Parkinson, H. Double gloving to reduce surgical cross-infection. Cochrane Database Syst. Rev. 2006, Cd003087. https:\/\/doi.org\/10.1002\/14651858.CD003087.pub2 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"49515_CR18","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1111\/jan.14824","volume":"77","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z., Gao, X., Ruan, X. & Zheng, B. Effectiveness of double-gloving method on prevention of surgical glove perforations and blood contamination: A systematic review and meta-analysis. J. Adv. Nurs. 77, 3630\u20133643. https:\/\/doi.org\/10.1111\/jan.14824 (2021).","journal-title":"J. Adv. Nurs."},{"key":"49515_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/vsu.12519","volume":"45","author":"LB Meakin","year":"2016","unstructured":"Meakin, L. B., Gilman, O. P., Parsons, K. J., Burton, N. J. & Langley-Hobbs, S. J. colored indicator undergloves increase the detection of glove perforations by surgeons during small animal orthopedic surgery: a randomized controlled trial. Vet. Surg. 45, 709\u2013714. https:\/\/doi.org\/10.1111\/vsu.12519 (2016).","journal-title":"Vet. Surg."},{"key":"49515_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/jce.12684","volume":"26","author":"N Shariff","year":"2015","unstructured":"Shariff, N. et al. Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation. J. Cardiovasc. Electrophysiol. 26, 783\u2013789. https:\/\/doi.org\/10.1111\/jce.12684 (2015).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"49515_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad224","author":"M Ziacchi","year":"2023","unstructured":"Ziacchi, M. et al. REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. REINFORCE Project Europace. https:\/\/doi.org\/10.1093\/europace\/euad224 (2023).","journal-title":"REINFORCE Project Europace"},{"key":"49515_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jacc.2022.10.022","volume":"81","author":"M Topaz","year":"2023","unstructured":"Topaz, M. et al. Regional antibiotic delivery for implanted cardiovascular electronic device infections. J. Am. Coll. Cardiol. 81, 119\u2013133. https:\/\/doi.org\/10.1016\/j.jacc.2022.10.022 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"49515_CR23","doi-asserted-by":"publisher","first-page":"101835","DOI":"10.1016\/j.jaccas.2023.101835","volume":"14","author":"M Giudice","year":"2023","unstructured":"Giudice, M. et al. Use of taurolidine in a patient with a cardiac implantable electronic device protrusion. JACC: Case Rep. 14, 101835. https:\/\/doi.org\/10.1016\/j.jaccas.2023.101835 (2023).","journal-title":"JACC: Case Rep."},{"key":"49515_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jcdd9010018","volume":"9","author":"J Weichsel","year":"2022","unstructured":"Weichsel, J. et al. Eradication of ventricular assist device driveline infection in paediatric patients with taurolidine. J. Cardiovasc. Dev. Disease. 9, 18 (2022).","journal-title":"J. Cardiovasc. Dev. Disease"},{"key":"49515_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s43057-022-00068-5","volume":"30","author":"S Borov","year":"2022","unstructured":"Borov, S., Baldauf, B., Lau, E. W. & Bonnemeier, H. Salvage of infected cardiac implantable electronic device with taurolidine\u2014a case report. Cardiothorac. Surgeon. 30, 7. https:\/\/doi.org\/10.1186\/s43057-022-00068-5 (2022).","journal-title":"Cardiothorac. Surgeon"},{"key":"49515_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/jcdd9030081","volume":"9","author":"M Giaccardi","year":"2022","unstructured":"Giaccardi, M., Baldauf, B., Lau, E. W., Borov, S. & Bonnemeier, H. Salvage of cardiac implantable electronic device pocket infection with skin erosion in frail 92-year-old. J. Cardiovasc. Dev. Disease. 9, 81 (2022).","journal-title":"J. Cardiovasc. Dev. Disease"},{"key":"49515_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00399-023-00940-9","author":"E Casorelli","year":"2023","unstructured":"Casorelli, E. et al. [Pacemaker infection in fragile patients]. Herzschrittmacherther Elektrophysiol. https:\/\/doi.org\/10.1007\/s00399-023-00940-9 (2023).","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"49515_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s44158-024-00155-5","volume":"4","author":"P Capuano","year":"2024","unstructured":"Capuano, P. et al. Fascial plane blocks for cardiothoracic surgery: a narrative review. J. Anesth. Analgesia Crit. Care. 4, 20. https:\/\/doi.org\/10.1186\/s44158-024-00155-5 (2024).","journal-title":"J. Anesth. Analgesia Crit. Care"},{"key":"49515_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.hroo.2023.12.002","volume":"5","author":"M Golian","year":"2024","unstructured":"Golian, M. et al. Adherent skin barrier drape use is associated with a reduced risk of cardiac implantable device infection: Results from a prospective study of 14,225 procedures. Heart Rhythm O2. 5, 103\u2013112. https:\/\/doi.org\/10.1016\/j.hroo.2023.12.002 (2024).","journal-title":"Heart Rhythm O2"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49515-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49515-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49515-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:31:59Z","timestamp":1781649119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49515-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49515"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49515-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BB is a medical consultant for\/part of the advisory board of: Abbott, Bioline Supply, Biotronik, Cablon NL, CRM Microport, Crosstec GmbH, Drugsales Limited, DSE T\u00fcrkiye, Implicity, Kappamed, Kimal PLC, M3 Medical\/Ecclipse Medical, Medival SRL, Medtronic, Philips\/Spectranetics, Sintec SRL, Tauro-Implant GmbH, Tauropharm GmbH, Transcutan, Transaxis. The other authors have no conflicts of interest to declareFunding: Open access publishing for this article was supported through a transformative agreement between the DEAL Consortium and Springer Nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, including the ethical principles set forth in the latest version of the Declaration of Helsinki. This Delphi consensus study was conducted exclusively among faculty members attending the 360 CIED Infection Congress on May 9th, 2025, in Florence, Italy.The survey was conducted fully anonymously; no personal identifiers, digital signatures, or traceable metadata were collected or stored. In accordance with EU GDPR Recital 26 and the guidance of the \u201cGarante per la Protezione dei Dati Personali\u201d, anonymous data that do not allow for the identification of individuals are not subject to data protection obligations. As such, the survey data qualify as anonymous, and a waiver of formal data protection review is granted. Although all participating faculty members are co-authors of this manuscript, the survey data were collected and analyzed in such a way that individual responses cannot be linked to any participant, thereby maintaining full anonymity throughout the consensus process. All experimental protocols were reviewed for compliance with institutional standards. Informed consent was obtained from all participating faculty members prior to the start of the survey, during the congress itself.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"13135"}}